Hillsdale Investment Management Inc. Fulgent Genetics, Inc. Transaction History

Hillsdale Investment Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$59.3 - $183.85 $6.26 Million - $19.4 Million	-105,552 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$31.01 - $52.1 $15,505 - $26,050	-500 Reduced 0.47%	105,552 $5.5 Million
Q3 2020 Nov 13, 2020	SELL	$15.89 - $50.51 $2.04 Million - $6.48 Million	-128,300 Reduced 54.75%	106,052 $4.25 Million
Q2 2020 Aug 11, 2020	SELL	$8.89 - $18.28 $758,317 - $1.56 Million	-85,300 Reduced 26.69%	234,352 $3.75 Million
Q1 2020 May 12, 2020	SELL	$6.75 - $19.75 $495,450 - $1.45 Million	-73,400 Reduced 18.67%	319,652 $3.44 Million
Q4 2019 Feb 12, 2020	BUY	$9.29 - $15.82 $391,592 - $666,844	42,152 Added 12.01%	393,052 $5.07 Million
Q3 2019 Nov 13, 2019	BUY	$5.96 - $12.81 $2.09 Million - $4.5 Million	350,900 New	350,900 $3.65 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $592M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.